文献速递骨质疏松与代谢性骨病

依据世界卫生组织诊断标准的骨质疏松症全球及区域患病率与危险因素:系统综述与Meta分析

Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis.
PubMed 文献 · Osteoporos Int · 2022-06-10

该系统综述与Meta分析通过检索PubMed、EMBASE、Web of Science和Scopus,纳入108项基于人群的研究、共343,704名受试者,评估依据世界卫生组织(WHO)标准的骨质疏松症全球及区域患病率。全球骨质疏松症患病率为19.7%(95%CI,18.0%-21.4%),骨量减少为40.4%(95%CI,36.9%-43.8%),患病率在不同国家(从荷兰4.1%到土耳其52.0%)和大洲(从大洋洲8.0%到非洲26.9%)间差异很大。发展中国家患病率(22.1%,95%CI,20.1%-24.1%)高于发达国家(14.5%,95%CI,11.5%-17.7%)。

要点

  • 全球骨质疏松症患病率为19.7%(95%CI,18.0%-21.4%),骨量减少为40.4%(95%CI,36.9%-43.8%)。
  • 患病率国家间从荷兰4.1%到土耳其52.0%,大洲间从大洋洲8.0%到非洲26.9%,差异很大。
  • 发展中国家患病率22.1%(95%CI,20.1%-24.1%)高于发达国家14.5%(95%CI,11.5%-17.7%)。

核心结论

  • 依据WHO标准,一般人群中骨质疏松症患病率相当可观,且国家和地区间差异很大。
  • 未来需要有力证据的研究来探索危险因素,为该病提供有效的预防策略。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE、Web of Science和Scopus,纳入报告基于WHO标准的骨质疏松症患病率的基于人群的研究。
  • 共评估57,933条文献,最终纳入108项独立研究,包含343,704名受试者。
  • 采用Meta回归和亚组分析探索异质性来源,研究注册于PROSPERO数据库(CRD42021285555)。

主要发现

  • 全球骨质疏松症患病率为19.7%(95%CI,18.0%-21.4%),骨量减少患病率为40.4%(95%CI,36.9%-43.8%)。
  • 患病率按国家从荷兰的4.1%到土耳其的52.0%,按大洲从大洋洲的8.0%到非洲的26.9%。
  • 发展中国家患病率为22.1%(95%CI,20.1%-24.1%),发达国家为14.5%(95%CI,11.5%-17.7%)。

关键数值与推荐

  • 骨质疏松症诊断依据世界卫生组织(WHO)标准。
  • 全球骨质疏松症患病率19.7%(95%CI,18.0%-21.4%),骨量减少40.4%(95%CI,36.9%-43.8%)。
  • 发展中国家患病率22.1%(95%CI,20.1%-24.1%) vs 发达国家14.5%(95%CI,11.5%-17.7%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出未来需要有力证据的研究来探索危险因素,以提供有效的预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This systematic review and meta-analysis estimated the global, regional prevalence, and risk factors of osteoporosis. Prevalence varied greatly according to countries (from 4.1% in Netherlands to 52.0% in Turkey) and continents (from 8.0% in Oceania to 26.9% in Africa). Osteoporosis is a common metabolic bone disorder in the elderly, usually resulting in bone pain and an increased risk of fragility fracture, but few summarized studies have guided global strategies for the disease. Therefore, we pooled the epidemiologic data to estimate the global, regional prevalence, and potential risk factors of osteoporosis. We conducted a comprehensive literature search through PubMed, EMBASE, Web of Science, and Scopus, to identify population-based studies that reported the prevalence of osteoporosis based on the World Health Organization (WHO) criteria. Meta-regression and subgroup analyses were used to explore the sources of heterogeneity. The study was registered in the PROSPERO database (CRD42021285555). Of the 57,933 citations evaluated, 108 individual studies containing 343,704 subjects were included. The global prevalence of osteoporosis and osteopenia was 19.7% (95%CI, 18.0%-21.4%) and 40.4% (95%CI, 36.9%-43.8%). Prevalence varied greatly according to countries (from 4.1% in Netherlands to 52.0% in Turkey) and continents (from Oceania 8.0% to 26.9% in Africa). The prevalence was higher in developing countries (22.1%, 95%CI, 20.1%-24.1%) than in developed countries (14.5%, 95%CI, 11.5%-17.7%). Our study indicates a considerable prevalence of osteoporosis among the general population based on WHO criteria, and the prevalence varies substantially between countries and regions. Future studies with robust evidence are required to explore risk factors to provide effective preventive strategies for the disease.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Xiao PL, Cui AY, Hsu CJ, et al. Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis. Osteoporos Int. 2022. PMID: 35687123. doi:10.1007/s00198-022-06454-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。